Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001468308-26-000018

CHIEF FINANCIAL OFFICER acquired 29,207 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Andrade Robert · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2026-03-31 Exercise or conversion : show line 1 in the form +14,724 271,380 D
2026-03-31 Exercise or conversion : show line 2 in the form +2,213 273,593 D
2026-03-28 Exercise or conversion : show line 3 in the form +12,270 285,863 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-31 Grant or award : show line 4 in the form Stock Options +120,000 $5.77 $692,400 921,045 D
Loading xslF345X06/form4-04022026_040401.xml…